Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
Top Cited Papers
- 1 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 166 (2), 131-137
- https://doi.org/10.1007/s00431-006-0223-z
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Infliximab treatment for refractory Kawasaki syndromeThe Journal of Pediatrics, 2005
- Association of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Gene Polymorphisms with Coronary Artery Lesions of Kawasaki DiseasePediatric Research, 2004
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidsThe Journal of Pediatrics, 1996
- Evaluation of the cytokine response in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1995
- Gamma globulin re-treatment in Kawasaki diseaseThe Journal of Pediatrics, 1993
- Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki diseaseThe Journal of Pediatrics, 1992
- Intravenous γ‐Globulin Treatment in Kawasaki DiseasePediatrics International, 1991
- ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASEThe Lancet, 1989
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984